Anti-Toxoplasma activity and impact evaluation of lyophilization, hot molding process, and gamma-irradiation techniques on CLH-PLGA intravitreal implants

详细信息    查看全文

• 作者：Gabriella M. Fernandes-Cunha…
• 刊名：Journal of Materials Science Materials in Medicine
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：27
• 期：1
• 全文大小：1,615 KB
• 参考文献：1.Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol. 1973;57(1):1鈥?7.CrossRef
  2.Rothova A, Suttorp-VanSchulten MS, Frits TW, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332鈥?.CrossRef
  3.Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12(3):348鈥?0.CrossRef
  4.Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2(2):47鈥?4.CrossRef
  5.Rothova A, Meenken C, Buitenhuis HJ, Brinkman CJ, Baarsma GS, Boen-Tan TN, de Jong PT, Klaassen-Broekema N, Schweitzer CM, Timmerman Z. Therapy for ocular toxoplasmosis. Am J Ophthalmol. 1993;115:517鈥?3.CrossRef
  6.Schoenwald RD. Ocular drug delivery: pharmacokinetic considerations. Clin Pharmacokinet. 1990;18:255鈥?9.CrossRef
  7.Martinez CE, Zhang D, Conway MD, Peyman GA. Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine. Int Ophthalmol. 1998;22:85鈥?.CrossRef
  8.Kishore K, Conway MD, Peyman GA. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers. 2001;32:183鈥?2.
  9.Sobrin L, Kump LI, Fosters CS. Intravitreal clindamycin for toxoplasmosis retinochoroiditis. Retina. 2007;27:952鈥?.CrossRef
  10.Soheilian M, Ramezani A, Azimzadeh A, Sadoughi MM, Dehghan MH, Shahghdami R, Yaseri M, Peyman GA. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. 2011;118:134鈥?1.CrossRef
  11.Fernandes-Cunha GM, Saliba JB, Siqueira RC, Jorge R, Silva-Cunha A. Determination of triamcinolone acetonide in silicone oil and aqueous humor of vitrectomized rabbits鈥檈yes: application for a pharmacokinetic study with intravitreal triamcinolone acetonide injections (Kenalog庐40). J Pharm Biomed Anal. 2014;89:24鈥?.CrossRef
  12.Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol. 2010;21(3):178鈥?3.CrossRef
  13.Bochot A, Fattal E. Liposomes for intravitreal drug delivery: a state of the art. J Control Release. 2012;161:628鈥?4.CrossRef
  14.Lee SS, Hughes P, Ross AD, Robinson MR. Biodegradable implants for sustained drug release in the eye. Pharm Res. 2010;27:2043鈥?3.CrossRef
  15.Siqueira RC, dos Santos WF, Scott IU, Messias A, Rosa MN, Fernandes-Cunha GM, Silva-Cunha A, Jorge R (2014) Neuroprotective effects of intravitreal triamcinolone acetonide and dexamethasone implant in rabbit retinas after pars plana vitrectomy and silicone oil injection. Retina 1鈥?.
  16.Bernards DA, Bhisitkul RB, Wynn P, Steedman MR, Lee OT, Wong F, Thoongsuwan S, Desai TA. Ocular biocompatibility and structural integrity of micro and nanostructured poly(caprolactone) films. J Ocul Pharmacol Ther. 2013;29(2):249鈥?7.CrossRef
  17.Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3:1377鈥?7.CrossRef
  18.Zhou T, Lewis H, Foster RE, Schwendeman SP. Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy. J Control Release. 1998;55:281鈥?5.CrossRef
  19.Garcia A, Tully J, Maynor B, Yerxa B. Precisely engineered biodegradable intraocular implants for the sustained release of dexamethasone. Investig Ophthalmol Vis Sci. 2013;54:1079.
  20.Chennamaneni SR, Mamalis C, Archer B, Oakey Z, Ambati BK. Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation. J Control Release. 2013;167(1):53鈥?.CrossRef
  21.Fernandes-Cunha GM, Gouvea DM, Fulgencio GO, Rezende CMF, Silva GR, Bretas JM, Fialho SL, Lopes NP, Silva-Cunha A. Development of a method to quantify clindamycin in vitreous humor of rabbits鈥?eyes by UPLC-MS/MS: application to a comparative pharmacokinetic study and in vivo ocular biocompatibility evaluation. J Pharm Biomed Anal. 2015;102:346鈥?2.CrossRef
  22.Tamaddon L, Mostafavi A, Riazi-esfahani M, Karkhane R, Aghazadeh S, Rafiee-Tehrani M, Dorkoosh FA, Amoli FA. Development, characterizations and biocompatibility evaluations of intravitreal lipid implants. Jundishapur J Nat Pharm Prod. 2014;9(2):e16414.CrossRef
  23.Tamaddon L, Mostafavi SA, Karkhane R, Riazi-Esfahani M, Dorkoosh FA, Rafiee-Tehrani M. Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis. Adv Biomed Res. 2015;4(32):1鈥?2.
  24.Chemburkar SR, Bauer J, Deming K, Spiwek H, Patel K, Morris J, Henry R, Spanton S, Dziki W, Porter W, Quick J, Bauer P, Donaubauer J, Narayanan BA, Soldani M, Riley D, McFarland K. Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development. Org Process Res Dev. 2000;4(5):413鈥?.CrossRef
  25.Franks F. Frezee-drying: from empiricism to predictability. The significance of glass transitions. Dev Biol Stand. 1992;74:9鈥?9.
  26.Sintzel MB, Merkli A, Tabatabay C, Gurny R. Influence of irradiation sterilization on polymers used as drug carriers鈥攁 review. Drug Dev Ind Pharm. 1997;23(9):857鈥?8.CrossRef
  27.Bittner B, M盲der K, Kroll C, Borchert HH, Kissel T. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of 纬-irradiation on radical formation and polymer degradation. J Control Release. 1999;59(1):23鈥?2.CrossRef
  28.Fialho SL, Silva-Cunha A. Manufacturing techniques of biodegradable implants intended to intraocular application. Drug Deliv. 2005;12:109鈥?6.CrossRef
  29.Chapiro A. Chemical modifications in irradiated polymers. Nucl Instrum Methods Phys Res B. 1988;32:111鈥?.CrossRef
  30.Food and Drug Administration( 2000) FDA guidance for industry: analytical procedures and methods validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville.
  31.Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55鈥?3.CrossRef
  32.Tanaka T, Omata Y, Saito A, Shimazaki K, Yamauchi K, Takase M, Kawase K, Igarashi K, Suzuki N. Toxoplasma gondii: parasiticidal effects of bovine lactoferricin against parasites. Exp Parasitol. 1995;81:614鈥?.CrossRef
  33.Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J Excip Food Chem. 2010;1(3):3鈥?6.
  34.Vukomanovi膰 M, Zava拧nik-Bergant T, Bra膷ko I, Skapin SD, Ignjatovi膰 N, Radmilovi膰 V, Uskokovi膰 D. Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 3: properties of hydroxyapatite nano-rods and investigation of a distribution of the drug within the composite. Colloids Surf B Biointerfaces. 2011;87(2):226鈥?5.CrossRef
  35.Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage鈥攊mpact of different polymers. J Pharm Sci. 2013;102(1):171鈥?4.CrossRef
  36.Bonadies I, Ambrogi V, Ascione L, Carfagna CA. A hyperbranched polyester as antinucleating agent for Artemisinin in electrospun nanofibers. Eur Polymer J. 2014;60:145鈥?2.CrossRef
  37.Blasi P, Schoubben A, Giovagnoli S, Perioli L, Ricci M, Rossi C. Ketoprofen Poly(lactide-co-glycolide) Physical Interaction. AAPS Pharm Sci Tech. 2007;8(2):E1鈥?.CrossRef
  38.Patel P, Patel P. Formulation and evaluation of clindamycin HCL in situgel for vaginal application. Int J Pharm Investig. 2015;5(1):50鈥?.CrossRef
  39.Costa HS, Mansur AAP, Pereira MM, Mansur HS. Engineered hybrid scaffolds of poly(vinyl alcohol)/bioactive glass for potential bone engineering applications: synthesis, characterization, cytocompatibility, and degradation. J Nanomater. 2012;. doi:10.鈥?155/鈥?012/鈥?18470 .
  40.Jenquin MR, McGinity JW. Characterization of acrylic resin matrix films and mechanisms of drug-polymer interactions. Int J Pharm. 1994;101:23鈥?4.CrossRef
  41.Evaluation of Medicines for Human Use CHMP Assessment report Ozurdex International Nonproprietary Name: dexamethasone Procedure No: EMEA/H/C/001140.
  42.脟ali艧 S, Bozda臒 S, Ka艧 HS, Tuncay M, Hincal AA. Influence of irradiation sterilization on poly(lactide-co-glycolide) microspheres containing anti-inflammatory drugs. II Farmaco. 2002;57(1):55鈥?2.CrossRef
  43.Wijsman JA, Dekaban GA, Rieder MJ. Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro. J Clin Pharmacol. 2005;45(3):346鈥?1.CrossRef
  44.Fichera ME, Bhopale MK, Roos DS. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma Gondii. Antimicrob Agents Chemother. 1995;39(7):1530鈥?.CrossRef
  45.Blais J, Tardif C, Chamberland S. Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii. Antimicrob Agents Chemother. 1993;37(12):2571鈥?.CrossRef
  46.Pfefferkorn ER, Nothnagel RF, Borotz SE. Parasiticidal effect of clindamycin on Toxoplasma gondii grow in culture cells and selection of a drug-resistant mutante. Antimicrob Agents Chemother. 1992;36(5):1091鈥?.CrossRef
  
• 作者单位：Gabriella M. Fernandes-Cunha (1)
  C铆ntia M. F. Rezende (2)
  Wagner N. Mussel (3)
  Gisele R. da Silva (4)
  Elionai C. de L. Gomes (5)
  Maria I. Yoshida (5)
  S铆lvia L. Fialho (6)
  Alfredo M. Goes (2)
  Dawison A. Gomes (2)
  Ricardo W. de Almeida Vitor (7)
  Armando Silva-Cunha (1)
  
  1. Faculty of Pharmacy of the Federal University of Minas Gerais, Av. Presidente Ant么nio Carlos, 6627, Belo Horizonte, MG, 31270-901, Brazil
  2. Department of Biochemistry and Immunology Department, Institute of Biological Science of the Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
  3. Chemistry Department of the Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
  4. School of Pharmacy, Federal University of Sao Joao del-Rei, Divin贸polis, MG, Bazil
  5. Laboratory of Thermal Analysis, Chemistry Department of the Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
  6. Ezequiel Dias Foundation, Belo Horizonte, MG, Brazil
  7. Department of Parasitology, Institute of Biological Science of the Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
  
• 刊物类别：Chemistry and Materials Science
• 刊物主题：Chemistry
  Biomaterials
  Characterization and Evaluation Materials
  Polymer Sciences
  Metallic Materials
  Ceramics,Glass,Composites,Natural Materials
  Surfaces and Interfaces and Thin Films
  
• 出版者：Springer Netherlands
• ISSN：1573-4838

文摘